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Abstract
Background: To assess interfraction translational and rotational setup errors, in patients treated with image-guded
hypofractionated stereotactic radiotherapy, immobilized by a thermoplastic mask and a bite-block and positioned
using stereotactic coordinates.
Methods: 37 patients with 47 brain metastases were treated with hypofractionated stererotactic radiotherapy. All
patients were immobilized with a combination of a thermoplastic mask and a bite-block fixed to a stereotactic
frame support. Daily cone-beam CT scans were acquired for every patient before the treatment session and were
matched online with planning CT images, for 3D image registration. The mean value and standard deviation of all
translational (X, Y, Z) and rotational errors (θx, θy, θz) were calculated for the matching results of bone matching
algorithm.
Results: A total of 194 CBCT scans were analyzed. Mean +/- standard deviation of translational errors (X, Y, Z) were
respectively 0.5 +/- 1.6 mm (range -5.7 and 5.9 mm) in X; 0.4 +/- 2.7 mm (range -8.2 and 12.1 mm) in Y; 0.4 +/- 1.9
mm (range -7.0 and 14 mm) in Z; median and 90th percentile were respectively within 0.5 mm and 2.4 mm in X,
0.3 mm and 3.2 mm in Y, 0.3 mm and 2.2 mm in Z. Mean +/- standard deviation of rotational errors (θx, θy, θz)
were respectively 0.0 degrees+/- 1.3 degrees (θx) (range -6.0 degrees and 3.1 degrees); -0.1 degrees +/- 1.1 degrees
(θy) (range -3.0 degrees and 2.4 degrees); -0.6 degrees +/- 1.4 degrees (θz) (range -5.0 degrees and 3.3 degrees).
Median and 90th percentile of rotational errors were respectively within 0.1 degrees and 1.4 degrees (θx), 0.0
degrees and 1.2 degrees (θy), 0.0 degrees and 0.9 degrees (θz). Mean +/- SD of 3D vector was 3.1 +/- 2.1 mm
(range 0.3 and 14.9 mm); median and 90th percentile of 3D vector was within 2.7 mm and 5.1 mm.
Conclusions: Hypofractionated stereotactic radiotherapy have the significant limitation of uncertainty in
interfraction repeatability of the patient setup; image-guided radiotherapy using cone-beam computed
tomography improves the accuracy of the treatment delivery reducing set-up uncertainty, giving the possibility of
3-dimensional anatomic informations in the treatment position.
Introduction
Brain is a common site for metastases. Stereotactic
radiosurgery (SRS) and hypofractionated stereotactic
radiotherapy (HSRT), due to their ability to deliver very
high doses to a small volume with high tumour control
rates [1], may be considered as a standard treatment for
patients with brain metastases. From a biological point
of view HSRT might have some advantage in compari-
son to SRS in terms of acute complications [2] and of
tumour control rate for lesions larger than 10 cc (or
more than 3 cm of diameter) [3,4]. In HSRT, daily treat-
ment reproducibility is necessary in order to avoid geo-
graphic miss of the target; as brain metastases are not
affected by internal organ motion and their position can
be considered stably correlated with bony structures,
patient set-up is the crucial step for the exact treatment
delivery. Several noninvasive systems are used for
patient immobilization, but verification of the patient
position is always necessary to enhance the precision of
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(IGRT) using cone-beam computed tomography (CBCT)
offers the possibility of a daily precise detection and cor-
rection of translational and rotational set-up errors.
The aim of this study was to assess inter-fraction
translational and rotational set-up errors, in patients
treated with IGRT-HSRT immobilized by a thermoplas-
tic mask and a bite-block and positioned using stereo-
tactic coordinates.
Methods and materials
Between April 2008 to September 2010, 37 patients with
47 brain metastases were treated with IGRT-HSRT at the
Radiation Oncology Therapy Unit of the University of
Rome, Tor Vergata. Inclusion criteria were: maximum 3
brain metastases, ≤ 3.5 cm of diameter and good perfor-
mance status (Karnofsky performance status ≥ 70). Table 1
summarized patient and treatment features. Primary can-
cers were non-small-cell lung cancer in the majority cases
(n = 17), breast cancer (n = 9), colon cancer (n = 4), mela-
noma (n = 3) and other sites (n = 4). The median planning
target volume of the 47 metastases was 2.3 cc (mean 1.6
cc; range 0.65 cc - 14.3 cc) with a median diameter of 16.7
mm (mean 14.5 mm; range 5 mm - 35 mm).
All patients were immobilized with a combination of a
thermoplastic mask (Head Mask R-PRT3, Klarity) and a
bite-block (3DLine
®) fixed to a stereotactic frame sup-
port (Head Frame, 3DLine
®); the frame for stereotactic
coordinate generation (Multimodality Localizer CT/MRI,
3DLine
®) was applied over the mask (Figure 1).
A contrast-enhanced CT scan (GE LightSpeed
® Scan-
ner; GE Healthcare Diagnostic Imaging, Slough, UK)
with a 1.25 mm slice thickness was acquired in axial
mode for planning. All patients had an MRI study that
was used for image registration in the planning; CT
images were transferred to Ergo stereotactic treatment
planning system (Elekta 3DLine
® Medical System PMM
Vers.1.6.3.1.) in order to contour the gross tumour
volume (GTV), that consisted of the radiographically
evident contrast-enhancing gross disease, and to deter-
mine the stereotactic localization of the isocenter. CT
images with a marker point (isocenter) and GTV con-
tours were transferred from Ergo to Pinnacle (Philips
Medical System, Andover, MA); CT and MRI images
were automatically registered on Syntegra software (Pin-
nacle, Philips Medical System, Andover, MA). The CT-
contoured GTV was corrected on CT-MRI registration;
planning target volume (PTV) and organs at risk
(OARs) were delineated. The PTV was defined as the
GTV plus a 3 mm isotropic margin. Treatment plans
were produced on Pinnacle3 version 8.0 m (Philips
Medical System, Andover, MA); multiple (5-9) no-copla-
nar beams (6 MV photons) were used to perform the
treatment plan. The median isodose at the periphery of
the PTV was 95%, the mean isodose 95.6% (range 91%-
100%); for every lesion the total dose was prescribed to
the isodose at the periphery of the PTV. Different frac-
tionation schedules were used, based on tumour size
and site: 3 fractions of 6 Gy (6 lesions), 4 fractions of 6
Gy (4 lesions), 5 fractions of 6 Gy (6 lesions), 2 fractions
o f1 5G y( 1l e s i o n ) ,4f r a c t i o n so f8G y( 2 9l e s i o n s ) ,5
fractions of 8 Gy (1 lesion). For every organ at risk we
started from the Biologic Effective Dose (BED) definition
















where n is the number of fractions, d is the fraction
dose.
Patients were treated with Linac Elekta Synergy
® S
(Elekta Oncology Systems, Crawley, UK) equipped with
Beam ModulatorTM (leaf width of 0.4 cm at the isocen-
ter) and a kilovolt (kV) imaging system capable of acquir-
ing 3D X-ray volume images based on kV cone-beam
computed tomography (CBCT). In particular CBCT has
the tube and flat panel imager both mounted on retract-
able arms that extend from the accelerator’sd r u ms t r u c -
ture. The kilovoltage system is mounted in an orthogonal
direction to the MV system sharing a common axis of
rotation. We used the “head and neck protocol” with the
following parameters: 100 kV, 36.1 mAs, nominal scan
dose 0.9 mGy, FOV (Field Of View) at the isocenter
Table 1 Patient and treatment characteristics













18 Gy (3 × 6 Gy) 6
24 Gy (4 × 6 Gy) 4
30 Gy (2 × 15 Gy) 1
30 Gy (5 × 6 Gy) 6
32 Gy (4 × 8 Gy) 29
40 Gy (5 × 8 Gy) 1
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control work station (XVI).
For every patient, planning CT images, with OARs,
PTV and marker isocenter were transferred from Pinna-
cle to XVI.
Daily CBCT scans were acquired for every patient before
the treatment session. Projections are acquired during a
single rotation of the gantry (about 113 s) and processed
with Elekta XVI software (XVI, Elekta, Crawley, United
Kingdom) that with a back-projection algorithm recon-
structs the 3D volumetric images. Reconstruction of about
625 projections is performed on a Intel Xeon (TM) 3.06
GHz processor and it takes about 30 s to reconstruct a
410 × 264 × 410 voxel matrix with voxel dimension 1 ×
1×1m m
3.
Planning CT images were matched online with the
daily CBCT images using bone-matching algorithm for
3D image registration (chamfer matching).
An alignment clip-box for volumes matching was
defined by the physicians. The registration was checked by
a physician using a “cut” display modality. After 3D regis-
tration the XVI software calculates translational and rota-
tional set-up errors. On-line corrections were performed
before each treatment. The translational errors were cor-
rected using the mechanical movements of the couch; the
rotational errors were corrected using the knobs of the
stereotactic head frame support.
If the translational and rotational errors in the first
set-up exceeded respectively 6 mm and/or 3 degrees,
the patient was repositioned.
The mean value and standard deviation of all transla-
t i o n a l( X ,Y ,Z )a n dr o t a t i o n a le r r o r s( θx, θy, θz)w e r e
calculated for the matching results of bone matching
algorithm. It was calculated the length of the transla-






To test the reproducibility of isocenter detection and
position correction an intense program of quality assur-
ance tests was performed: a home made phantom and
an anthropomorphic phantom were used to assess error
correction performance [5].
Results
A total of 194 CBCT scans were retrospectively analyzed
to evaluate the positioning errors obtained by automatic
bone alignment. Before each fraction of hypofractionated
stereotactic radiation therapy a CBCT was acquired with
the “head and neck protocol” and a clip-box involving
skull, pneumatic sinusal structure and clivus was chosen
to determine the match volume (Figure 2).
For the 194 CBCT, mean, median, standard deviation
(SD), 90
th percentile and range of set-up errors were
calculated along the three major directions [lateral (X),
cranio-caudal (Y) and antero-posterior (Z)] considering
Figure 1 Patient immobilized with the combination of the thermoplastic mask and the bite-block fixed to the stereotactic frame
support, with the frame for stereotactic coordinate generation applied over the mask.
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fractions. The same parameters were evaluated for rota-
tional set-up errors (θx), (θy), (θz).
The results of the corrections obtained by XVI soft-
ware are listed in Table 2. Mean ± SD of translational
errors (X, Y, Z) were respectively 0.5 ± 1.6 mm (X axis)
(range -5.7 and 5.9 mm); 0.4 ± 2.7 mm (Y axis) (range
-8.2 and 12.1 mm); 0.4 ± 1.9 mm (Z axis) (range -7.0
and 14 mm).
Median and 90
th percentile of translational errors were
respectively within 0.5 mm and 2.4 mm (X axis), 0.3
mm and 3.2 mm (Y axis), 0.3 mm and 2.2 mm (Z axis).
Mean ± SD of rotational errors (θx, θy, θz)w e r e
respectively 0.0° ± 1.3° (θx) (range -6.0° and 3.1° mm);
-0.1° ± 1.1° (θy) (range -3.0° and 2.4°); -0.6° ± 1.4° (θz)
(range -5.0° and 3.3°).
Median and 90
th percentile of rotational errors were
respectively within 0.1° and 1.4° (θx), 0.0° and 1.2° (θy),
0.0° and 0.9° (θz). Mean ± SD of 3D vector was 3.1 ± 2.1
mm (range 0.3 and 14.9 mm); median and 90
th percen-
tile of 3D vector was within 2.7 mm and 5.1 mm.
Discussion
Stereotactic radiotherapy is a treatment modality for
brain metastases to deliver very high doses to a small
volume and to obtain high tumour control rates. Hypo-
fractionated stereotactic radiotherapy has the advantage
Table 2 Patient repositioning errors (194 CBCT)
tranlations (mm) rotations (°)
xy z 3 D
vector
θx θy θz
mean 0.5 0.4 0.4 3.1 0 -0.1 -0.6
SD 1.6 2.7 1.9 2.1 1.3 1.1 1.4
median 0.5 0.3 0.3 2.7 0.1 0 0
90th
percentile













Figure 2 Cone-beam computed-tomography (CBCT) matched with the planning CT using the clip-box involving skull, pneumatic
sinusal structure and clivus.
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radioresistant tumours- with the radiobiological features
of fractionation [6,7]; in fact, from a biological point of
view it seems to be better than SRS in terms of acute
complications [2] and of tumour control rate for lesions
larger than 10 cc [3,4]. To avoid geographic miss of the
target and to spare organs at risk from irradiation, high
precision in the daily set-up is required. In stereotactic
radiosurgery this precision can be achieved using an
invasive rigid fixation of the skull to a stereotactic sys-
tem that is placed for immobilization before the plan-
ning, and it is removed at the end of the treatment
delivery. In fractionated stereotactic radiotherapy we use
non invasive fixation, such as bite-block and/or a mask
system, introducing a significant variation in daily set-
up. The uncertainties, related to the non invasive fixa-
tion system, can result from different causes such as
weight changes of the patient (weight gain for patients
receiving steroids), different mask-making technique,
thermoplastic mask shrinking [8].
The combination of two relocatable immobilization
devices, such as thermoplastic mask and bite-block, is
more effective for head treatment-position reproducibil-
ity. Recently, Masi et al. evaluated set-up errors mea-
sured by a CBCT for patients immobilized by a
thermoplastic mask and a bite-block; when patients
were completely repositioned, the set-up corrections
were significantly larger than those measured when
patients were left immobilized, and set-up errors mea-
sured with mask alone were larger than those obtained
with a mask and a bite-block, but not with statistically
significant difference. In the analysis of 131 CBCT for
57 patients receiving SRT, they obtained an overall
mean and standard deviation for the 3D vector of 3.0 ±
1.4 mm and a maximum standard deviation of 2.4 mm
that was observed along the cranio-caudal direction [9].
In the study of Boda-Heggemann et al. [10] the
accuracy of two different mask systems (rigid mask vs
thermoplastic mask), using CBCT three-dimensional
matching, was compared; the mean module of 3D dis-
placement vector was 3.1 mm ± 1.5 mm for patients
immobilized with rigid mask and 4.7 ± 1.7 mm for
those immobilized with the thermoplastic mask; Guck-
enberger et al. measured a mean three-dimensional
set-up error of 4.0 ± 2.1 mm according to the bony
anatomy of the skull, in 18 patients treated with
image-guided stereotactic radiotherapy using kv-
CBCT. All these patients underwent a CBCT and a
conventional CT after injection of i.v. contrast, just
before the treatment session. Set-up errors using auto-
matic bone registration (CBCT) and manual soft tissue
registration of brain metastases (conventional CT)
were compared, demonstrating a significant correla-
tion between the two types of registration (r ≥ 0.88)
and thus the great accuracy of daily repositioning with
image-guidance based on the bony anatomy of the
skull that can be used as a surrogate for the actual
target position [11].
In the present study we evaluated set-up accuracy
using automatic image registration between on-board
kV CBCT and planning CT scan, based on a clipbox
involving the base of the skull; a system based on mask
and bite-block immobilization was used. A total of 194
CBCT have been examined. We obtained an overall
mean and standard deviation for the 3D vector of 3.1 ±
2.1 mm, that is comparable with data obtained by other
authors, with a range of the 3D vector between 0.3 mm
and 14.9 mm; we registered the widest range of set-up
errors in the cranio-caudal direction (between -7 mm
and 14 mm). The analysis of daily repositioning errors
shows that errors related to mask-making technique and
patient compliance have to be considered for a stereo-
tactic treatment; in our series in 17 cases we had a
translational error exceeding 6 mm and/or a rotational
error > 3 degrees and we repeated all the set-up proce-
dure assuming that this difference was attributable to
the wrong position of the head into the mask, most of
all due to the movements of the joint between the occi-
pital bone and the first cervical vertebra, or to radiation
therapist random errors.
The accuracy of automatic 3D-3D matching for eva-
luation of patient set-up is better than manual 2D-2D
matching; for Elekta XVI automatic registration, phan-
tom studies have shown errors less than 0.5 mm [12,13].
The fractionated stereotactic radiotherapy needs IGRT
on-line corrections; on-board Kv CBCT, acquiring volu-
metric images inside the treatment room, allows daily
detection and correction of systematic and random
errors before each treatment session, with a small-dose
exposure and good image quality [14-17].
Conclusions
In our analysis stereotactic fractionated radiotherapy
have the significant limitation of uncertainty in inter-
fraction repeatability of the patient set-up; IGRT using
cone-beam computed tomography improves the accu-
racy of the treatment delivery reducing set-up uncer-
tainty, giving the possibility of 3-dimensional anatomic
informations in the treatment position.
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